Lancashire and South Cumbria
Formulary
Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-04-04 Bladder instillations and urological surgery
For bladder cancer see sections 8.1.2 (mitomycin) and 8.2.4 (BCG)
For bladder cancer see sections 8.1.2 (mitomycin) and 8.2.4 (BCG)
| Dimethyl sulfoxide (DMSO) installation |
|
Formulary
|
Bladder instillation 50% 50mL Interstitial cystitis. |
|
Unlicensed| Sodium hyaluronate & Sodium chondroitin sulphate bladder instillation (iAluRil) |
|
Formulary
|
Pain due to interstitial cystitis. |
|
|
Links
FSRH Clinical Guideline: Contraceptive Choices for Young People- FSRH: Standards & Guidance
- FSRH: UK Medical Eligibility Criteria for Contraceptive Use (UKMEC)
LSCMMG: Primary Care Management of Erectile Dysfunction- LSCMMG: Primary Care Management of Overactive Bladder in Female Adults
- MHRA alert: Anaphylaxis risk with chlorhexidine
- MHRA alert: Anaphylaxis risk with chlorhexidine
- MHRA: Medical Device Alert
- MHRA: Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
- NICE CG30: Long-acting reversible contraception
- NICE CG97: Lower urinary tract symptoms in men: management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG194: Postnatal care
- NICE NG210: Pelvic floor dysfunction: prevention and non-surgical management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- NICE NG88: Heavy menstrual bleeding: assessment and management